Zoledronic and Ibandronate sodium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zoledronic (zoledronic acid) and Ibandronate sodium (ibandronate sodium). Common drug interactions include swelling among females and femur fracture among males.
The phase IV clinical study analyzes what interactions people have when they take Zoledronic and Ibandronate sodium. It is created by eHealthMe based on reports of 186 people who take the same drugs from the FDA, and is updated regularly.
What is Zoledronic?
Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.
What is Ibandronate sodium?
Ibandronate sodium has active ingredients of ibandronate sodium. It is often used in osteoporosis post-menopausal. eHealthMe is studying from 3,549 Ibandronate sodium users. Check the latest studies of Ibandronate sodium.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
186 people who take Zoledronic and Ibandronate sodium together, and have interactions are studied.

What are the common drug interactions of Zoledronic and Ibandronate sodium, by gender? *
What are the common drug interactions of Zoledronic and Ibandronate sodium, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zoledronic and Ibandronate sodium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Zoledronic (29,812 reports)
- Ibandronate sodium (3,549 reports)
Browse all drug interactions of Zoledronic and Ibandronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zoledronic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibandronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoledronic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibandronate sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid and ibandronate sodium (the active ingredients of Zoledronic and Ibandronate sodium, respectively), and Zoledronic and Ibandronate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Synthroid cause Infrequent Bowel Movements? - 4 seconds ago
- Could Flolan cause Hepatic Congestion? - 12 seconds ago
- Could Synribo cause Red Blood Cell Count Decreased? - 14 seconds ago
- Could Magnesium Sulfate cause Gingivitis? - 17 seconds ago
- Could Novorapid cause Hepatic Encephalopathy? - 22 seconds ago
- Could Cefazolin cause Dry Eyes? - 25 seconds ago
- Could Azmacort cause Nosebleed? - 28 seconds ago
- Could Biotin cause Hyperhidrosis? - 28 seconds ago
- Could Duragesic cause Arrhythmias? - 32 seconds ago
- Could Neurontin cause Gastrointestinal Obstruction? - 34 seconds ago